Low-dose cyclophosphamide combined with chinese herbal medicine Shuli Fenxiao formula for the treatment of intermediate-to-high risk primary membranous nephropathy

Authors

Yuning Liu
Yiyu Liang (ORCID: https://orcid.org/0000-0003-0548-3892)
Zhen Wang (ORCID: https://orcid.org/0000-0002-5301-1673)
Jingwei Zhou (ORCID: https://orcid.org/0009-0003-1617-9447)
Xia Li (ORCID: https://orcid.org/0000-0003-0848-5463)
Weihong Chen (ORCID: https://orcid.org/0000-0001-9205-5399)
Yong Du (ORCID: https://orcid.org/0000-0002-4187-3989)
Xiaowen Li (ORCID: https://orcid.org/0000-0001-9776-5680)
Qingqing Liu (ORCID: https://orcid.org/0000-0002-3051-8295)
Zhiyan Chen (ORCID: https://orcid.org/0000-0002-0192-418X)
Ying Wang (ORCID: https://orcid.org/0000-0001-9038-4762)
Zhongjie Liu (ORCID: https://orcid.org/0000-0003-0790-3635)
Jie Lv (ORCID: https://orcid.org/0009-0001-1830-1165)

Institutions

Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine (CN)
Xiyuan Hospital (CN)

Publication Details

Journal: Frontiers in Immunology
Published: 2025-04-22
DOI: https://doi.org/10.3389/fimmu.2025.1543581
Citations: 2
Primary Topic: Renal Diseases and Glomerulopathies
Type: article
Field-Weighted Citation Impact: 2.86

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Low-dose cyclophosphamide combined with chinese herbal medicine Shuli Fenxiao formula for the treatment of intermediate-to-high risk primary membranous nephropathy

Yuning Liu, Yiyu Liang, Zhen Wang, Jingwei Zhou et al.

Apr 22, 2025

2 citations

Frontiers in Immunology

Renal Diseases and Glomerulopathies

2.86

article

Low-dose cyclophosphamide combined with chinese herbal medicine Shuli Fenxiao formula for the treatment of intermediate-to-high risk primary membranous nephropathy

Yuning Liu, Yiyu Liang, Zhen Wang, Jingwei Zhou, Xia Li, Weihong Chen, Yong Du, Xiaowen Li, Qingqing Liu, Zhiyan Chen, Ying Wang, Zhongjie Liu, Jie Lv

April 22, 2025article en

2 citations

Abstract

No abstract available for this paper.

Frontiers in ImmunologyVol. 16

Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine (CN), Xiyuan Hospital (CN)

Good health and well-being

Openalex Percentile: Top 11%

Renal Diseases and Glomerulopathies

2.86

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Low-dose cyclophosphamide combined with chinese herbal medicine Shuli Fenxiao formula for the treatment of intermediate-to-high risk primary membranous nephropathy — Yuning Liu, Yiyu Liang, et al. · Frontiers in Immunology (2025) | TGRS Research Map | TGRS